SMDAM
CLBT icon

Sumitomo Mitsui DS Asset Management’s Cellebrite CLBT Stock Holding History

Sumitomo Mitsui DS Asset Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,534
Closed -$186K – 772
2026
Q1 		$186K Buy
13,534
+1,318
+11% +$19.9K ﹤0.01% 753
2025
Q4 		$220K Buy
12,216
+1,850
+18% +$33.2K ﹤0.01% 744
2025
Q3 		$192K Buy
+10,366
New +$163K ﹤0.01% 741

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Sumitomo Mitsui DS Asset Management's CLBT Position: Q2 2026 in Review

Sumitomo Mitsui DS Asset Management sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 13,534 shares — an estimated $186K sold.

Sumitomo Mitsui DS Asset Management first reported a position in CLBT in Q3 2025 and held it in 3 quarters. The position peaked at $220K in Q4 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Sumitomo Mitsui DS Asset Management reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • Sumitomo Mitsui DS Asset Management sold 13,534 Cellebrite shares in Q2 2026, an estimated $186K.
  • Sumitomo Mitsui DS Asset Management first reported a position in Cellebrite in Q3 2025 and held it in 3 quarters.
  • Sumitomo Mitsui DS Asset Management's Cellebrite position peaked at $220K in Q4 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.